Clinical Study
Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)
Full Title
A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of Tobacco Heating System 2.2 (THS 2.2) Following Single Use in Smoking, Healthy Subjects Compared to Conventional Cigarettes and Nicotine Nasal Spray.
Authored by
PMI
Abstract
The primary objective of this clinical study is to evaluate the pharmacokinetic (PK) profile (rate and amount of nicotine absorbed) following a single use of the THS 2.2 compared to the PK profiles from a single use of a conventional cigarette (CC) and from a single use of nicotine nasal spray (NNS).
Summary
Recruitment | Completed |
Study Results | Has Results |
Enrollment | 62 |
Study Type | Interventional |
Other IDs | ZRHR-PK-01-EU|2013-003097-27 |
-
Published On
March 3, 2017 -
Full publication
-
Identifier
NCT01967732